We are live on ! Find out more
KP

Kiltearn Partners Portfolio holdings

AUM $372M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+15.37%
1 Year Est. Return
+18.16%
3 Year Est. Return
+34.48%
5 Year Est. Return
+43.43%
10 Year Est. Return
+168.94%
AUM
$1.36B
AUM Growth
-$363M
Cap. Flow
-$590M
Cap. Flow %
-43.34%
Top 10 Hldgs %
52.51%
Holding
36
New
2
Increased
5
Reduced
24
Closed
5

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$29.9M
2
HCA icon
HCA Healthcare
HCA
+$29.2M
3
MDT icon
Medtronic
MDT
+$15.8M
4
AMAT icon
Applied Materials
AMAT
+$15.6M
5
FDX icon
FedEx
FDX
+$14.8M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$63.2M
2
SLB icon
SLB Ltd
SLB
+$54.5M
3
AMG icon
Affiliated Managers Group
AMG
+$51.9M
4
C icon
Citigroup
C
+$49.7M
5
BWA icon
BorgWarner
BWA
+$49.2M

Sector Composition

Rank Sector Weight
1 Financials 17.56%
2 Consumer Discretionary 15.67%
3 Healthcare 14.8%
4 Communication Services 13.42%
5 Industrials 12.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
26
American Express
AXP
$224B
$24M 1.76%
162,223
-65,807
-29% -$9.75M
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.1T
$23.6M 1.73%
76,520
-1,900
-2% -$564K
AZO icon
28
AutoZone
AZO
$51.4B
$17.7M 1.3%
7,183
-12,010
-63% -$29M
STT icon
29
State Street
STT
$48.4B
$17.6M 1.3%
227,500
-311,300
-58% -$22.9M
MDT icon
30
Medtronic
MDT
$112B
$15.2M 1.12%
+195,500
New +$15.8M
QVCGA
31
DELISTED
QVC Group Inc Series A
QVCGA
$13.2M 0.97%
161,844
-57,920
-26% -$5.91M
BMY icon
32
Bristol-Myers Squibb
BMY
$129B
-349,500
Closed -$24.8M
BWA icon
33
BorgWarner
BWA
$12.8B
-1,779,885
Closed -$49.2M
C icon
34
Citigroup
C
$213B
-1,193,096
Closed -$49.7M
CSCO icon
35
Cisco
CSCO
$444B
-534,900
Closed -$21.4M
SLB icon
36
SLB Ltd
SLB
$72.7B
-1,517,926
Closed -$54.5M

Similar funds

Kiltearn Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Kiltearn Partners held 36 positions worth $1.36B, down 21% from $1.73B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Kiltearn Partners withdrew a net $590M in Q4 2022, closing 5 positions and reducing 24 holdings. Its most notable exit was SLB Ltd, an estimated $54.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Kiltearn Partners opened a new position in HCA Healthcare worth $31.3M.

  • Kiltearn Partners's largest Q4 2022 buy was HCA Healthcare: 130,400 shares worth $31.3M.
  • Kiltearn Partners added most to Alphabet (Google) Class A in Q4 2022, an estimated $29.9M increase.
  • Kiltearn Partners's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $63.2M.
  • Kiltearn Partners fully exited SLB Ltd in Q4 2022, selling an estimated $54.5M.
  • Kiltearn Partners's ten largest holdings make up 53% of its $1.36B portfolio in Q4 2022.
  • Kiltearn Partners opened 2 new positions and closed 5 in Q4 2022.
  • Kiltearn Partners's portfolio value fell 21% quarter-over-quarter to $1.36B.

Based on Kiltearn Partners's 13F filing for Q4 2022, filed 9 Feb 2023.